Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Generon (Shanghai) Corporation Ltd.
ClinicalTrials.gov Identifier:
NCT01648322
First received: April 27, 2012
Last updated: January 26, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)